Answers are grounded in this paper and cite their sources.
Background Contemporary data on severe pediatric hepatitis A in Somalia are limited. This study describes clinical characteristics, documented liver failure, and in-hospital outcomes among hospitalized pediatric patients. Methods We conducted a hospital-based retrospective cohort study using FONET electronic health records and aggregate hospital screening statistics from 1 January 2020 to 31 December 2025. All included children had a positive serum immunoglobulin M antibody to hepatitis A virus (IgM anti-HAV) result verified in the laboratory section during the index admission. Documented liver failure was defined by the binary clinical diagnosis recorded in FONET and was analyzed without retrospective reclassification. Clinical-record review confirmed no pre-existing chronic liver disease; however, response of coagulopathy to parenteral vitamin K was unavailable, preventing independent adjudication of pediatric acute liver failure. Non-parametric comparisons and parsimonious logistic regression were used. Results From 1 January 2020 to 31 December 2025, 78,132 pediatric admission episodes were recorded, and 1,024 children were evaluated for suspected acute hepatitis. Of these, 691 were excluded (not identified as acute hepatitis A) after clinical and laboratory evaluation, leaving 333 serum IgM anti-HAV-positive records corresponding to 330 unique patient identifiers. After removing of one exact duplicate record and excluding 2 patients with unresolved discrepant duplicate records, a final sample of 328 children was included in the analysis. The median age was 4.0 (2.0–7.0) years, and 185 (56.4%) were boys. Documented liver failure occurred in 76 patients [23.2%; 95% confidence interval (CI), 18.9%–28.0%], hepatic encephalopathy was recorded in 31 of 325 children (9.5%), and 23 patients died (7.0%; 95% CI, 4.7%–10.3%). Each doubling of total bilirubin was associated with higher odds of documented liver failure [adjusted odds ratio (aOR), 1.46; 95% CI, 1.18–1.81], whereas higher albumin was associated with lower odds (aOR per 1 g/dL, 0.31; 95% CI, 0.19–0.50). Higher albumin was also associated with lower in-hospital mortality (aOR, 0.21; 95% CI, 0.10–0.42). Conclusions Documented liver failure and in-hospital mortality represented substantial clinical burdens in this hospitalized cohort. Total bilirubin and albumin were independently associated with documented liver failure, whereas albumin was associated with mortality. These findings represent clinical associations rather than a validated prediction model.
No takes yet. Share an insight, caveat, or question.
Abdilahi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: